9/6/2019 7:01:53 AM
Invitae Prices $300.0 Mln Of 2.00% Convertible Senior Notes Due 2024 (
9/4/2019 4:27:05 PM
Invitae Announces Proposed Offering Of $200 Mln Of Convertible Senior Notes
6/17/2019 7:35:26 AM
Invitae To Buy Singular Bio; Acquisition To Close In The Coming Weeks; Transaction Will Be Cash Neutral At Close
6/12/2019 7:33:18 AM
Invitae Announces Launch Of ID YOUR IRD Initiative
3/6/2019 9:35:38 PM
Invitae Announces Exercise In Full Of Underwriters' Option To Purchase Additional Shares Of Common Stock
3/5/2019 8:37:26 PM
Invitae Prices Underwritten Public Offering Of 9 Mln Shares At $19.00/shr
3/4/2019 4:10:25 PM
Invitae Announces Proposed Public Offering Of Common Stock
2/19/2019 4:09:14 PM
Invitae Q4 Loss/share $0.40 Vs. Loss $0.78 Year Ago
10/29/2018 7:32:59 AM
Invitae Corp Expands Partnership With Alnylam Pharma To Provide Access To Genetic Testing For Primary Hyperoxaluria
9/11/2018 8:09:49 AM
Invitae Appoints Chitra Nayak To Its Board
3/28/2018 6:01:58 AM
Invitae Prices Underwritten Public Offering Of 11.1 Mln Shares At $4.50/shr